Skandinaviska Enskilda Banken AB:企業のM&A・事業提携・投資動向

◆英語タイトル:Skandinaviska Enskilda Banken AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1387
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:124
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Skandinaviska Enskilda Banken AB – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Skandinaviska Enskilda Banken AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Skandinaviska Enskilda Banken AB since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Skandinaviska Enskilda Banken AB’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Skandinaviska Enskilda Banken AB. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Skandinaviska Enskilda Banken AB’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Skandinaviska Enskilda Banken AB and its subsidiaries since 2007.
- Information about key financial and legal advisors for Skandinaviska Enskilda Banken AB’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Skandinaviska Enskilda Banken AB’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Deal reports 8
CORPORATE VENTURING 23
Corporate Venturing – Deal reports 23
PARTNERSHIP 28
Partnership – Overview 28
Partnership – Deal reports 29
CAPITAL RAISING 35
Capital Raising – Overview 35
Capital Raising – Deal reports 36
DIVESTMENTS 44
Divestments – Overview 44
Divestments – Deal reports 45
APPENDIX 114
Contact Us 114
About MarketLine Financial Deals Database 114
Deal Definition and Methodology 116
About MarketLine 123

List of Tables
Table 1: Skandinaviska Enskilda Banken AB partnership volume and value trend (2014-YTD2018)
Table 2: Skandinaviska Enskilda Banken AB capital raising volume and value trend (2014-YTD2018)
Table 3: Skandinaviska Enskilda Banken AB capital raising by deal type (2014-YTD2018)
Table 4: Skandinaviska Enskilda Banken AB divestments volume and value trend (2014-YTD2018)
Table 5: Skandinaviska Enskilda Banken AB divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Skandinaviska Enskilda Banken AB partnership volume and value trend (2014-YTD2018)
Figure 2: Skandinaviska Enskilda Banken AB capital raising volume and value trend (2014-YTD2018)
Figure 3: Skandinaviska Enskilda Banken AB capital raising by deal type (2014-YTD2018)
Figure 4: Skandinaviska Enskilda Banken AB divestments volume and value trend (2014-YTD2018)
Figure 5: Skandinaviska Enskilda Banken AB divestments by geography (2014-YTD2018)

★海外企業調査レポート[Skandinaviska Enskilda Banken AB:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IntriCon Corp (IIN):企業の財務・戦略的SWOT分析
    Summary IntriCon Corp (IntriCon) is a designer, developer and manufacturer of miniature and micro-miniature body-worn medical and electronics products. The company’s products comprise value hearing health, biomedical solutions, hearing health manufacturing and professional audio. In addition it also …
  • Feilo Sylvania Europe Ltd:企業の戦略的SWOT分析
    Feilo Sylvania Europe Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Martindale Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Martindale Pharmaceuticals Ltd (Martindale), a subsidiary of Cardinal Health Inc is a pharmaceutical company that offers formulations. The company provides hospital-initiated medicines in emergency medicine and differentiated products in complex neurological conditions,opioid addiction and p …
  • Beximco Pharmaceuticals Ltd (BXPHARMA):企業の財務・戦略的SWOT分析
    Summary Beximco Pharmaceuticals Ltd (Beximco Pharma) is a manufacturer and exporter of generic medicines and active pharmaceutical ingredients (APIs). The company offers products in the therapeutic areas of allergic disorders, analgesics and antipyretic, anti-infectives, cardiovascular, central nerv …
  • Daybreak Oil and Gas Inc (DBRM):企業の財務・戦略的SWOT分析
    Summary Daybreak Oil and Gas Inc (Daybreak) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include East Slopes project and Michigan Basin project. Its East Slopes project is located in south-eastern art of the San Joaquin Basin, California. Da …
  • Guardant Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Guardant Health Inc (Guardant Health) is a non-invasive cancer diagnostics company that commercializes genomic liquid biopsy. The company develops proprietary digital sequencing technology used to detect individual genomic alterations. It offers Guardant360, a tool for early cancer detection …
  • Kate Spade & Company LLC:企業の戦略・SWOT・財務分析
    Kate Spade & Company LLC - Strategy, SWOT and Corporate Finance Report Summary Kate Spade & Company LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Victory Oilfield Tech Inc (VYEY):石油・ガス:M&Aディール及び事業提携情報
    Summary Victory Oilfield Tech, Inc (Victory Oilfield Tech) is an oilfield energy-technology products company that acquires, develops and produces natural gas, crude oil, and other energy fuels. The company offers acquisition and development of unconventional resource play opportunities in the Permia …
  • The Israel Electric Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary The Israel Electric Corporation Ltd (IECL), formerly Palestine Electric Corporation Ltd. is an integrated electric utility that carries out the generation, transmission, distribution, sale and supply of electricity. The State of Israel owns around 99.85% of the company. It generates power ma …
  • Limacorporate SpA-医療機器分野:企業M&A・提携分析
    Summary Limacorporate SpA (Lima) is a medical device company that offers reconstructive and fixation orthopaedic solutions. The company offers large joint primary, large joint revision, extremities and fixation and promade products. It offers medical products for knee, hip, shoulder, cups, small joi …
  • China Petroleum & Chemical Corporation (Sinopec):戦略・SWOT・企業財務分析
    China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Smiths Detection Group Limited:戦略・SWOT・企業財務分析
    Smiths Detection Group Limited - Strategy, SWOT and Corporate Finance Report Summary Smiths Detection Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Apple Inc:戦略・SWOT・企業財務分析
    Apple Inc - Strategy, SWOT and Corporate Finance Report Summary Apple Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Helius Medical Technologies Inc (HSDT):企業の財務・戦略的SWOT分析
    Summary Helius Medical Technologies Inc (HMT) is a medical device company that provides neurological wellness solutions. The company provides development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It provides development of tec …
  • Universal Biosensors Inc (UBI)-医療機器分野:企業M&A・提携分析
    Summary Universal Biosensors Inc (UBI) is a medical diagnostic company. The company researches, develops and manufactures in vitro diagnostic test devices that are used for professional and consumer point-of-care. The company is working with Siemens Healthcare to develop a range of products for the …
  • BASF Corp:企業のM&A・事業提携・投資動向
    BASF Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BASF Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Papyrus Australia Limited (PPY):企業の財務・戦略的SWOT分析
    Papyrus Australia Limited (PPY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Quad/Graphics, Inc.:企業の戦略・SWOT・財務情報
    Quad/Graphics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Quad/Graphics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • OsteoVantage Inc:製品パイプライン分析
    Summary OsteoVantage Inc (OsteoVantage) is a medical device company that develops osteogenic spinal instrumentation technology used in spinal fusion procedures. The company’s INDOS system is an osteogenic spinal instrumentation for use in lumbar spinal fusion procedures. It also offers osteomodulati …
  • Weifa AS-製薬・医療分野:企業M&A・提携分析
    Summary Weifa AS (Weifa), a subsidiary of Weifa ASA, is a healthcare solution provider that research, develops, produces, distributes and sells medicines, and lifestyle products. The company’s products comprise Tylenol, paracetduo, ibux, ibux gel, tiger balm, proxan, nazareth, dexyl, tussin, bronkyl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆